The private label CBD gummies market is poised for significant growth, with projections indicating an increase from USD 646.2 million in 2026 to USD 1,382.2 million by 2036, according to a new report from Future Market Insights (FMI). This represents a compound annual growth rate (CAGR) of 7.9% over the forecast period. The market, valued at USD 598.9 million in 2025, is being propelled by a growing preference among wellness brands for outsourced manufacturing and white label production models that reduce launch costs and shorten commercialization timelines.
As competition intensifies in the functional wellness industry, companies are increasingly turning to private label CBD gummies to enter the market without investing in extraction facilities or confectionery manufacturing infrastructure. This trend is further supported by retailers and regulators placing greater emphasis on batch testing, ingredient traceability, labeling accuracy, and compliance documentation, which encourages manufacturers to strengthen quality assurance and transparency throughout the supply chain.
The white label gummies service model is projected to dominate the market, accounting for 46.2% of global demand in 2026. This model offers shorter commercialization timelines, lower formulation costs, and established manufacturing processes, enabling new wellness brands to enter the market quickly. By leveraging existing formulations and production capabilities, white label manufacturers allow companies to focus on branding, marketing, and customer acquisition.
In terms of CBD spectrum, broad-spectrum CBD gummies are expected to capture 42.8% of market demand in 2026. This is driven by increasing consumer preference for THC-free wellness products while retaining multiple naturally occurring cannabinoids. Broad-spectrum formulations provide an attractive balance between perceived wellness benefits and simplified regulatory positioning, which is crucial as retailers adopt stricter product review procedures.
Brand websites are the leading sales channel, representing 39.6% of global demand in 2026. Direct-to-consumer platforms give manufacturers and wellness brands greater control over customer education, product positioning, subscription programs, and repeat purchasing. Unlike traditional retail, these channels allow brands to communicate dosage guidance, laboratory testing information, and quality certifications before purchase, which is increasingly important as regulatory scrutiny surrounding CBD products grows.
Geographically, North America continues to dominate the global market, with the United States projected to be the fastest-growing country, registering a CAGR of 8.5% through 2036. This growth is supported by a mature CBD ecosystem, expanding direct-to-consumer brands, and well-established contract manufacturing capabilities. Other key markets include Canada (8.1% CAGR), the United Kingdom (7.8% CAGR), and Germany (7.5% CAGR).
The market is not without challenges. Regulatory complexity surrounding CBD health claims, labeling requirements, cannabinoid content verification, and product safety documentation remains a significant restraint. Differences in CBD regulations across countries can delay commercialization, increase compliance costs, and limit retail expansion for emerging brands.
Key trends shaping the industry include growing investment in white label manufacturing solutions, broad-spectrum and THC-free formulations, customized gummy formulations targeting specific wellness needs such as sleep and relaxation, and enhanced third-party laboratory testing and batch traceability. Additionally, sustainable packaging and clean-label product development are gaining traction, along with subscription-based direct-to-consumer business models.
Major companies operating in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., CV Sciences, Inc., Medterra CBD LLC, British Cannabis, Cannaray Limited, MediPharm Labs Corp., and Little Green Pharma Ltd. These players are competing on formulation expertise, manufacturing scalability, compliance support, and private label service offerings.
For detailed market forecasts, competitive benchmarking, and pricing trends, visit the full report at Future Market Insights.
